Meet Anya Fletcher—a pharmacist turned postdoctoral fellow—who joined CSL through our U.S. Fellowship Program. Over two years, Anya explored multiple areas of Medical Affairs, from medical information to publications and strategy, gaining hands-on experience and mentorship every step of the way. “If I didn’t try it, how would I know?” That mindset, paired with CSL’s rotational structure and supportive culture, helped Anya discover her passion and build a strong foundation for her career. At CSL, we don’t just offer fellowships—we offer Promising FUTURES. With real projects, real impact, and real growth, our people are empowered to lead, learn, and thrive. Join a company where your work is valued, your growth is supported, and your team feels like family. Explore open roles across CSL and discover how you can build a future with purpose. Explore Careers at CSL https://bit.ly/3GWwPwl #PromisingFutures #LifeAtCSL #MedicalAffairs #EarlyCareers #LeadershipDevelopment #PharmaCareers #PostdocLife
We Have Released Our
2025 Annual Report
CSL's 2025 Full Year Financial Results Click here for Full Information including Webcast Recording →
CSL. Always Evolving for a Better World.
CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.
Our Businesses and Products
CSL. Always Evolving for a Better World.
CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.
Our Businesses and Products
CSL Behring. Leading the Way in Treating Rare and Serious Diseases.
CSL Behring is a global biotech leader with a broad range of biotherapies for rare and serious diseases including bleeding disorders, immunodeficiencies, hereditary angioedema, neurological disorders and Alpha 1 Antitrypsin Deficiency.
More About CSL Behring
CSL Seqirus. Global Vaccine Leader.
Through the power of innovation, our vision is to advance science to enhance public health worldwide. We stand on the front line with partners in public health discovering, developing, and delivering pioneering vaccine solutions to safeguard people and communities across the world.
More About CSL Seqirus
CSL Vifor. Changing the Game in Iron Deficiency and Nephrology.
The newest member of the CSL family, CSL Vifor is a global leader in iron deficiency and nephrology and is committed to launching the next generation of therapies to truly address the full spectrum of kidney disease, with a focus on dialysis and rare disease.
More About CSL ViforVita: Original Stories
'Vita' means life. It's also where we share the stories of biotech's promise to patients and public health.
Careers at CSL
We are committed to helping employees fulfill their career aspirations while working in a values-based culture. Are you next?
Pictured: A CSL employee in Bern, Switzerland
At CSL, our studies are co-designed with patient input. Here’s a snapshot of what patients with end-stage kidney disease and their support squad recommend for those considering participation in a #clinicaltrial . #CSL #PatientFocus Read more: https://bit.ly/3JLnDvF.
Dr. Paul McKenzie, our CEO and Managing Director, shares some of our highlights from financial year 2025. See how we're driving growth and accelerating our clinical and commercial pipelines in order to deliver enduring patient impact in areas of high unmet need. For the full presentation, including important disclaimers and notes supporting financial information, visit our investor center: https://bit.ly/4oHE8ZG #CSL #FY25 #FullYearResults
Today we shared our full-year results for FY25. Take a look at some of the key financial and operational highlights. For more details visit our Investor Centre: https://bit.ly/4mfn6AC #CSL #FullYearResults
Learn more about the 2025 CSL Community Impact Award scholarship recipients! These outstanding organisations will join the Emerging Social Purpose Leaders Program, delivered by Melbourne Business School’s Centre for Social Purpose Organisations. This initiative supports organisations making a real difference in our communities. Congratulations to all the CSL Community Impact Award recipients - we’re excited to see the ongoing impact you’ll create. Click the link to learn more: https://lnkd.in/e5NGyG5c #CSL #CommunityImpactAwards
The first and only once-monthly treatment targeting factor XIIa to prevent recurrent attacks of hereditary angioedema \(HAE\) has been authorized by Health Canada. This marks the seventh approval of this innovative therapy worldwide, reflecting CSL’s decades-long commitment to delivering innovative treatments to offer those living with HAE a convenient administration method for long-term control over their disease. Learn more: https://bit.ly/46MYCtN
Meet the 2025 CSL Community Impact Award winners! We’re proud to support these incredible organisations making a lasting difference across Australia, from allergy care and heart health to sport inclusion and food insecurity. Together, we’re helping expand their reach and deepen their impact for patients and communities across Australia. Click the link to learn more: https://lnkd.in/e5NGyG5c #CSL #CommunityImpactAwards
For more than a century, CSL has advanced public health through trusted science and innovative therapies. #CSL #PublicHealth #InnovationForLife See our impact: https://bit.ly/4lcO6zq
🎉 Take a look inside our award-winning #CSLBehring plasma base fractionation facility at Broadmeadows in Victoria, Australia! 🌏 Broadmeadows was recently named 2025 Facility of the Year in the category of Pharma 4.0 by the International Society for Pharmaceutical Engineering (ISPE ). The manufacturing site was honored for its “full-scale” use of robotics and automation technologies. Learn more about the Australian manufacturing site, which turns human plasma into critical medicines: https://bit.ly/3GLhDlO #CSL #Australia #ISPE #Engineering #Manufacturing #Broadmeadows
At CSL, support goes beyond the workplace. We’re proud to invest in the futures of our employees and their loved ones through the Promising Futures Scholarship Program. This initiative helps employees and their dependents—especially those overcoming barriers—pursue higher education and unlock new opportunities. Because when we support our people and their families, we build stronger communities and a brighter future for all. Ready to grow your career with a company that supports your whole family? https://bit.ly/3GIfhUJ #CSL #CSLCareers #PromisingFutures #LifeAtCSL
